Nuzenio

First Patient

First Patient news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Patient Gift Monday ready for more after first WAFCON goal for Nigeria - ESPNESPN · Fri, 07 Aug 2026 15:18:33 GMT First Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMT Harvard Medical, Dental Class of 2030 Receives White Coats, Warm Welcome - Harvard Medical SchoolHarvard Medical School · Fri, 07 Aug 2026 12:00:00 GMT First patient dosed in clinical study about stroke-related disability - Scientist LiveScientist Live · Fri, 07 Aug 2026 11:17:21 GMT First patient dosed with DISP-10 in Dispatch Bio’s cancer trial - YahooYahoo · Fri, 07 Aug 2026 09:47:43 GMT Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.comclinicaltrialvanguard.com · Fri, 07 Aug 2026 06:44:00 GMT Innovent Doses First Patient in Phase 3 Trial of IBI363 for Advanced Colorectal Cancer - BioPharma APACBioPharma APAC · Fri, 07 Aug 2026 01:05:55 GMT SystImmune doses first patient in Phase III trial for ES-SCLC - clinicaltrialsarena.comclinicaltrialsarena.com · Thu, 06 Aug 2026 10:25:17 GMT

Timeline

Fri, 07 Aug 2026 15:18:33 GMTPatient Gift Monday ready for more after first WAFCON goal for Nigeria - ESPN

Fri, 07 Aug 2026 13:04:40 GMTFirst Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted Oncology

Fri, 07 Aug 2026 12:00:00 GMTHarvard Medical, Dental Class of 2030 Receives White Coats, Warm Welcome - Harvard Medical School

Fri, 07 Aug 2026 11:17:21 GMTFirst patient dosed in clinical study about stroke-related disability - Scientist Live

Fri, 07 Aug 2026 09:47:43 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Yahoo

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.com

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Trial13 live mentions Phase10 live mentions First Patient Dosed5 live mentions Registration4 live mentions First4 live mentions Announces First Patient4 live mentions Registrational Phase4 live mentions First Patient Enrolled3 live mentions Patient3 live mentions Doses First Patient3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Patient.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.